Cardiovascular Disease

To tackle inequalities, build health into all public policies

Many of today's public health issues – diabetes, cancer, obesity, cardiovascular disease – are strongly associated with social inequalities. Literature from across the world shows that gaps in income, employment, education and access to acute ...

Jan 16, 2015
popularity 2.5 / 5 (2) | comments 0

Does coconut oil live up to the hype?

Every month there seems to be a new "superfood" that is promoted heavily on the Internet and TV talk shows and endorsed by semi-celebrities. But rarely has a food gone through as dramatic a transformation ...

Jan 16, 2015
popularity 3.9 / 5 (31) | comments 0

Eczema woes not just skin deep

Eczema wreaks havoc on its sufferers' lives with health problems that are more than skin deep. Adults who have eczema—a chronic itchy skin disease that often starts in childhood—have higher rates of smoking, drinking ...

Jan 15, 2015
popularity 5 / 5 (1) | comments 0

Does screening asymptomatic adults for disease save lives?

New paper published online today in the International Journal of Epidemiology says that randomized controlled trials (the gold standard method of evaluation) show that few currently available screening tests for major diseas ...

Jan 14, 2015
popularity not rated yet | comments 0

Latest Spotlight News

Popular antioxidant likely ineffective, study finds

The popular dietary supplement ubiquinone, also known as Coenzyme Q10, is widely believed to function as an antioxidant, protecting cells against damage from free radicals. But a new study by scientists at McGill University ...

Research suggests brain's melatonin may trigger sleep

If you walk into your local drug store and ask for a supplement to help you sleep, you might be directed to a bottle labeled "melatonin." The hormone supplement's use as a sleep aid is supported by anecdotal ...

New understanding of stroke damage may aid recovery

Stroke can lead to a wide range of problems such as depression and difficulty moving, speaking and paying attention. Scientists have thought these issues were caused by damage to the brain's "computer processors"—cells ...

FDA approves first lower-cost biotech drug (Update)

Federal health officials have approved the first lower-cost copy of a biotech drug to reach the U.S. market, a long-awaited milestone that could generate billions in savings for insurers, doctors and patients.